Tiziana Life Sciences Ltd.: Tiziana Life Sciences Ltd (Tiziana or the Company) - Interim Results for the Six Months Ended 30 June 2022
Advancing pipeline of next generation therapeutics and diagnostics for oncology and immune diseases of high unmet needLONDON, Dec. 27, 2022 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd ("Tiziana", NASDAQ:
Source: finanznachrichten.de